Clinical Pre-screening Protocol for Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beatson West of Scotland Cancer Centre
Glasgow, Scotland, United Kingdom
Active, not recruiting - Guy'S and St Thomas' Nhs Foundation Trust, Guy'S Hospital
London, United Kingdom
Active, not recruiting
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Completed - Ou Health Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
Kathleen Moore, MDRecruiting - Swedish Center for Research and Innovation
Seattle, Washington, United States
Fernanda Baptista Musa, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Apr 2019
- Primary completion
- 30 Sept 2026
- Completion
- 31 Dec 2026
- Last update posted
- 30 Oct 2025
- Registered enrollment
- 60
- Registry id
- NCT03877796
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.